Neuberg Diagnostics Said to Eye $350 Million India IPO in 2026

Nov. 11, 2025, 5:27 AM UTC

Neuberg Diagnostics Pvt. is said to be planning an initial public offering that could raise about $350 million for the Indian clinical laboratory-testing chain, according to people familiar with the matter, adding to flurry of deals in the country’s hot IPO market.

The Chennai-based company is in active discussions with investment bankers for the IPO and is aiming for a listing next year, people said, asking not to be identified as the information is private.

Its founder, GSK Velu, who owns other health care ventures as well, is planning to list medical device supplier Trivitron Healthcare and eyecare ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.